Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director

Synta Pharmaceuticals Corp. (NASDAQ: SNTA ) today announced that Safi R. Bahcall, Ph.D., has resigned as President, Chief Executive Officer and a member of the Board of Directors, effective immediately, and has been replaced by a newly formed Executive Committee of the Board. The Committee will be chaired by